Trends in aetiology‐based hospitalisation for cirrhosis before and during the <scp>COVID</scp>‐19 pandemic in the United States
Donghee Kim(Chungnam National University), Aijaz Ahmed(Stanford University), Karn Wijarnpreecha(University of Arizona), Richie Manikat(Stanford University), Brandon J. Perumpail(St. Christopher's Hospital for Children), George Cholankeril(Baylor College of Medicine)
Cited by 11
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Nonobese Fatty Liver Disease
|Clinical Gastroenterology and Hepatology|2016|346
Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management
|World Journal of Hepatology|2017|183
Current epidemiology of chronic liver disease
|Gastroenterology report|2023|56
Hepatitis E in solid organ transplant recipients: A systematic review and meta-analysis
|World Journal of Gastroenterology|2021|41